메뉴 건너뛰기




Volumn 21, Issue 2-3, 2014, Pages 79-87

Innate immune system and inflammation in Alzheimer's disease: From pathogenesis to treatment

Author keywords

Alzheimer's disease; Cytokines; Immune system; Immunization; Inflammation; Microglia; Vaccination

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; CHEMOKINE; CYTOKINE; MONOCLONAL ANTIBODY; TAU PROTEIN;

EID: 84901786502     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000356529     Document Type: Article
Times cited : (73)

References (71)
  • 1
    • 0033600274 scopus 로고    scopus 로고
    • Translating cell biology into therapeutic advances in Alzheimer's disease
    • Selkoe DJ: Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399:A23-A31.
    • (1999) Nature , vol.399 , pp. A23-A31
    • Selkoe, D.J.1
  • 3
    • 84865676982 scopus 로고    scopus 로고
    • Engeneered antibody approaches for Alzheimer's disease immunotherapy
    • Robert R, Wark KL: Engeneered antibody approaches for Alzheimer's disease immunotherapy. Arch Biochem Biophys 2012; 132-138.
    • (2012) Arch Biochem Biophys , pp. 132-138
    • Robert, R.1    Wark, K.L.2
  • 4
    • 34147096369 scopus 로고    scopus 로고
    • Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: A position paper
    • Finch CE, Morgan TE: Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. Curr Alzheimer Res 2007; 4: 185-189.
    • (2007) Curr Alzheimer Res , vol.4 , pp. 185-189
    • Finch, C.E.1    Morgan, T.E.2
  • 5
    • 4944258716 scopus 로고    scopus 로고
    • The role of inflammation in Alzheimer's disease
    • Tuppo EE, Arias HR: The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 2005; 37: 289-305.
    • (2005) Int J Biochem Cell Biol , vol.37 , pp. 289-305
    • Tuppo, E.E.1    Arias, H.R.2
  • 6
    • 0034612175 scopus 로고    scopus 로고
    • Inflammation and Alzheimer's disease
    • Akiyama H, Barger S, Barnum S, et al: Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421.
    • (2000) Neurobiol Aging , vol.21 , pp. 383-421
    • Akiyama, H.1    Barger, S.2    Barnum, S.3
  • 7
    • 0141853765 scopus 로고    scopus 로고
    • Amyloid-β: A chameleon walking in two worlds: A review of the trophic and toxic properties of amyloid-β
    • Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA, Martins RN: Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β. Brain Res Rev 2003; 43: 1-16.
    • (2003) Brain Res Rev , vol.43 , pp. 1-16
    • Atwood, C.S.1    Obrenovich, M.E.2    Liu, T.3    Chan, H.4    Perry, G.5    Smith, M.A.6    Martins, R.N.7
  • 8
    • 33846887598 scopus 로고    scopus 로고
    • Microglial control of neuronal death and synaptic properties
    • Bessis A, Bechade C, Bernard D, Roumier A: Microglial control of neuronal death and synaptic properties. Glia 2007; 55: 233-238.
    • (2007) Glia , vol.55 , pp. 233-238
    • Bessis, A.1    Bechade, C.2    Bernard, D.3    Roumier, A.4
  • 10
    • 34248392684 scopus 로고    scopus 로고
    • Microglial activation and its implications in the brain diseases
    • Dheen ST, Kaur C, Ling EA: Microglial activation and its implications in the brain diseases. Curr Med Chem 2007; 14: 1189-1197.
    • (2007) Curr Med Chem , vol.14 , pp. 1189-1197
    • Dheen, S.T.1    Kaur, C.2    Ling, E.A.3
  • 13
    • 0035866060 scopus 로고    scopus 로고
    • β-Amyloid stimulation of microglia anti monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis
    • Combs CK, Karlo JC, Kao SC, Landreth GE: β-Amyloid stimulation of microglia anti monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 2001; 21: 1179-1188.
    • (2001) J Neurosci , vol.21 , pp. 1179-1188
    • Combs, C.K.1    Karlo, J.C.2    Kao, S.C.3    Landreth, G.E.4
  • 17
    • 0027051448 scopus 로고
    • Hertz: Regulatory role of astrocytes for neuronal biosynthesis and homeostasis of glutamate and GABA
    • Schousboe A, Westergaard N, Sonnerwald U, Petersen SB, Yu AC, L: Hertz: Regulatory role of astrocytes for neuronal biosynthesis and homeostasis of glutamate and GABA. Prog Brain Res 1992; 94: 199-211.
    • (1992) Prog Brain Res , vol.94 , pp. 199-211
    • Schousboe, A.1    Westergaard, N.2    Sonnerwald, U.3    Petersen, S.B.4    Yu, A.C.L.5
  • 18
    • 33645382898 scopus 로고    scopus 로고
    • Cytokine production
    • Kettnman H, Ransom B (eds), Oxford, Oxford University
    • Aloisi F: Cytokine production; in Kettnman H, Ransom B (eds): Neuroglia. Oxford, Oxford University, 2005, pp 285-301.
    • (2005) Neuroglia , pp. 285-301
    • Aloisi, F.1
  • 19
    • 0036942730 scopus 로고    scopus 로고
    • Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-γ
    • Strack A, Asensio VC, Campbell IL, Schluter D, Deckert M: Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-γ. Acta Neuropathol 2002; 103: 458-468.
    • (2002) Acta Neuropathol , vol.103 , pp. 458-468
    • Strack, A.1    Asensio, V.C.2    Campbell, I.L.3    Schluter, D.4    Deckert, M.5
  • 21
    • 0034523456 scopus 로고    scopus 로고
    • Costimulatory effects of interferon-γ and interleukin-1β or tumor necrosis factor-α on the synthesis of Aβ1-40 and Aβ1-42 by human astrocytes
    • Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B: Costimulatory effects of interferon-γ and interleukin-1β or tumor necrosis factor-α on the synthesis of Aβ1-40 and Aβ1-42 by human astrocytes. Neurobiol Dis 2000; 7: 682-689.
    • (2000) Neurobiol Dis , vol.7 , pp. 682-689
    • Blasko, I.1    Veerhuis, R.2    Stampfer-Kountchev, M.3    Saurwein-Teissl, M.4    Eikelenboom, P.5    Grubeck-Loebenstein, B.6
  • 22
    • 14744283139 scopus 로고    scopus 로고
    • Differential effects of oligomeric and fibrillar amyloid-β1-42 on astrocyte-mediated inflammation
    • White JA, Manelli AM, Holmberg KH, Van Eldik LJ, Ladu MJ: Differential effects of oligomeric and fibrillar amyloid-β1-42 on astrocyte-mediated inflammation. Neurobiol Dis 2005; 18: 459-465.
    • (2005) Neurobiol Dis , vol.18 , pp. 459-465
    • White, J.A.1    Manelli, A.M.2    Holmberg, K.H.3    Van Eldik, L.J.4    Ladu, M.J.5
  • 23
    • 0035127243 scopus 로고    scopus 로고
    • Cytokines regulate expression of the type 1 interleuken-1 receptor in rat hippocampal neurons and glia
    • Friedman WJ: Cytokines regulate expression of the type 1 interleuken-1 receptor in rat hippocampal neurons and glia. Exp Neurol 2001; 168: 23-31.
    • (2001) Exp Neurol , vol.168 , pp. 23-31
    • Friedman, W.J.1
  • 24
    • 0033621568 scopus 로고    scopus 로고
    • S100-β induction of the pro-inflammatory cytokine interleukin-6 in neurons: Implications for Alzheimer pathogenesis
    • Li Y, Barger SW, Liu L, Mrak RE, Griffin WST: S100-β induction of the pro-inflammatory cytokine interleukin-6 in neurons: implications for Alzheimer pathogenesis. J Neurochem 2000; 74: 143-150.
    • (2000) J Neurochem , vol.74 , pp. 143-150
    • Li, Y.1    Barger, S.W.2    Liu, L.3    Mrak, R.E.4    Griffin, W.S.T.5
  • 25
    • 0037080187 scopus 로고    scopus 로고
    • Tumor necrosis factor expressed by primary hippocampal neurons SH-SY5Y cells is regulated by α 2 -adrenergic receptor activation
    • Renauld AE, Spengler RN: Tumor necrosis factor expressed by primary hippocampal neurons SH-SY5Y cells is regulated by α 2 -adrenergic receptor activation. J Neurosci Res 2002; 67: 264-274.
    • (2002) J Neurosci Res , vol.67 , pp. 264-274
    • Renauld, A.E.1    Spengler, R.N.2
  • 27
    • 0030897761 scopus 로고    scopus 로고
    • Inflammatory cytokines in the CNS
    • McGeer E, McGeer P: Inflammatory cytokines in the CNS. CNS Drugs 1997; 7: 214-287.
    • (1997) CNS Drugs , vol.7 , pp. 214-287
    • McGeer, E.1    McGeer, P.2
  • 28
    • 0032621790 scopus 로고    scopus 로고
    • TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs
    • Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B: TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs. FASEB J 1999; 13: 63-68.
    • (1999) FASEB J , vol.13 , pp. 63-68
    • Blasko, I.1    Marx, F.2    Steiner, E.3    Hartmann, T.4    Grubeck-Loebenstein, B.5
  • 29
    • 1542283611 scopus 로고    scopus 로고
    • Neuroinflammatory perspectives on the two faces of Alzheimer's disease
    • Eikelenboom P, Van Gool WA: Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J Neural Transm 2004; 111: 281-294.
    • (2004) J Neural Transm , vol.111 , pp. 281-294
    • Eikelenboom, P.1    Van Gool, W.A.2
  • 30
    • 0035690976 scopus 로고    scopus 로고
    • Interleukin-1, neuroinflammation, and Alzheimer's disease
    • Mrak RE, Griffin WST: Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 2001; 22: 903-908.
    • (2001) Neurobiol Aging , vol.22 , pp. 903-908
    • Mrak, R.E.1    Griffin, W.S.T.2
  • 31
    • 0034620481 scopus 로고    scopus 로고
    • Anti-inflammatory drugs and Alzheimer type pathologyin aging
    • Mackenzie IR: Anti-inflammatory drugs and Alzheimer type pathologyin aging. Neurology 2000; 54: 732-734.
    • (2000) Neurology , vol.54 , pp. 732-734
    • Mackenzie, I.R.1
  • 32
    • 0345580623 scopus 로고    scopus 로고
    • Cytokine actions in the central nervous system
    • Benveniste EN: Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 1998; 9: 259-275.
    • (1998) Cytokine Growth Factor Rev , vol.9 , pp. 259-275
    • Benveniste, E.N.1
  • 33
    • 0025092159 scopus 로고
    • Proliferation of astrocytes in vitro in response to cytokines: A primary role for tumor necrosis factor
    • Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF: Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor. J Immunol 1990; 144: 129-135.
    • (1990) J Immunol , vol.144 , pp. 129-135
    • Selmaj, K.W.1    Farooq, M.2    Norton, W.T.3    Raine, C.S.4    Brosnan, C.F.5
  • 34
    • 0031028141 scopus 로고    scopus 로고
    • Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain
    • Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH: Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 1997; 94: 1500-1505.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 1500-1505
    • Heyser, C.J.1    Masliah, E.2    Samimi, A.3    Campbell, I.L.4    Gold, L.H.5
  • 35
    • 0033168292 scopus 로고    scopus 로고
    • IL-6 (IL-6) production by astrocytes: Autocrine regulation by IL-6 and the soluble IL-6 receptor
    • Van Wagoner NJ, Oh JW, Repovic P, Benveniste EN: IL-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci 1999; 19: 5236-5244.
    • (1999) J Neurosci , vol.19 , pp. 5236-5244
    • Van Wagoner, N.J.1    Oh, J.W.2    Repovic, P.3    Benveniste, E.N.4
  • 36
    • 84155162481 scopus 로고    scopus 로고
    • Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases
    • Smith JA, Das A, Ray SK, Banik NL: Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 2012; 87: 10-20.
    • (2012) Brain Res Bull , vol.87 , pp. 10-20
    • Smith, J.A.1    Das, A.2    Ray, S.K.3    Banik, N.L.4
  • 38
    • 17844392320 scopus 로고    scopus 로고
    • Cytokine and chemokine interregulation in the inflamed or injured CNS
    • Owens T, Babcock AA, Millward JM, Toft-Hansen H: Cytokine and chemokine interregulation in the inflamed or injured CNS. Brain Res Rev 2005; 48: 178-184.
    • (2005) Brain Res Rev , vol.48 , pp. 178-184
    • Owens, T.1    Babcock, A.A.2    Millward, J.M.3    Toft-Hansen, H.4
  • 39
    • 0032917904 scopus 로고    scopus 로고
    • Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease
    • Xia M, Hyman BT: Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J Neurovirol 1999; 5: 32-41.
    • (1999) J Neurovirol , vol.5 , pp. 32-41
    • Xia, M.1    Hyman, B.T.2
  • 41
    • 0031848322 scopus 로고    scopus 로고
    • Immunohistochemical study of the β-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains
    • Xia MQ, Qin SX, Wu LJ, Mackay CR, Hyman BT: Immunohistochemical study of the β-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am J Pathol 1998; 153: 31-37.
    • (1998) Am J Pathol , vol.153 , pp. 31-37
    • Xia, M.Q.1    Qin, S.X.2    Wu, L.J.3    Mackay, C.R.4    Hyman, B.T.5
  • 43
    • 79951757581 scopus 로고    scopus 로고
    • Managing cognitive dysfunction through the continuum of Alzheimer's disease: Role of pharmacotherapy
    • Delrieu J, Piau A, Caillaud C, Voisin T, Vellas B: Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy. CNS Drugs 2011; 25: 213-226.
    • (2011) CNS Drugs , vol.25 , pp. 213-226
    • Delrieu, J.1    Piau, A.2    Caillaud, C.3    Voisin, T.4    Vellas, B.5
  • 44
    • 0029811901 scopus 로고    scopus 로고
    • Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
    • McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996; 47: 425-432.
    • (1996) Neurology , vol.47 , pp. 425-432
    • McGeer, P.L.1    Schulzer, M.2    McGeer, E.G.3
  • 45
    • 84856723844 scopus 로고    scopus 로고
    • Progress in Alzheimer's disease
    • Galimberti D, Scarpini E: Progress in Alzheimer's disease. J Neurol 2012; 259: 201-211.
    • (2012) J Neurol , vol.259 , pp. 201-211
    • Galimberti, D.1    Scarpini, E.2
  • 47
    • 84880189986 scopus 로고    scopus 로고
    • Immunotherapy for Alzheimer's disease
    • Morgan D: Immunotherapy for Alzheimer's disease. J Alzheimer Dis 2006; 9: 425-432.
    • (2006) J Alzheimer Dis , vol.9 , pp. 425-432
    • Morgan, D.1
  • 48
    • 0030058382 scopus 로고    scopus 로고
    • Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer β-amyloid peptide
    • Solomon B, Koppel R, Hanan E, Katzav T: Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer β-amyloid peptide. Proc Natl Acad Sci USA 1996; 93: 452-455.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 452-455
    • Solomon, B.1    Koppel, R.2    Hanan, E.3    Katzav, T.4
  • 52
    • 84856479445 scopus 로고    scopus 로고
    • Targeting beta amyloid: A clinical review of immunotherapic approaches in Alzheimer's disease
    • Lobello K, Ryan MJ, Liu E, Rippon G, Black R: Targeting beta amyloid: a clinical review of immunotherapic approaches in Alzheimer's disease. Int J Alzheimers Dis 2012; 2012: 628070.
    • (2012) Int J Alzheimers Dis , vol.2012 , pp. 628070
    • Lobello, K.1    Ryan, M.J.2    Liu, E.3    Rippon, G.4    Black, R.5
  • 56
    • 84884910087 scopus 로고    scopus 로고
    • Immunotherapy against amyloid pathology in Alzheimer's disease
    • Galimberti D, Ghezzi L, Scarpini E: Immunotherapy against amyloid pathology in Alzheimer's disease. J Neurol Sci 2013; 333: 50-54.
    • (2013) J Neurol Sci , vol.333 , pp. 50-54
    • Galimberti, D.1    Ghezzi, L.2    Scarpini, E.3
  • 59
    • 79955803502 scopus 로고    scopus 로고
    • Solanezumab for Alzheimer's disease
    • Samadi H, Sultzer D: Solanezumab for Alzheimer's disease. Expert Opin Biol Ther 2011; 11: 787-798.
    • (2011) Expert Opin Biol Ther , vol.11 , pp. 787-798
    • Samadi, H.1    Sultzer, D.2
  • 60
  • 61
    • 33745001453 scopus 로고    scopus 로고
    • Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice
    • Wilcock DM, Alamed J, Gottschall PE, Grimm J, Rosenthal A, Pons J, Ronan V, Symmonds K, Gordon MN, Morgan D: Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice. J Neurosci 2006; 26: 5340-5346.
    • (2006) J Neurosci , vol.26 , pp. 5340-5346
    • Wilcock, D.M.1    Alamed, J.2    Gottschall, P.E.3    Grimm, J.4    Rosenthal, A.5    Pons, J.6    Ronan, V.7    Symmonds, K.8    Gordon, M.N.9    Morgan, D.10
  • 62
    • 0141457897 scopus 로고    scopus 로고
    • Amyloid-β immunization effectively reduces amyloid deposition in FcRγ -/- knock-out mice
    • Das P, Howard V, Loosbrock N, Dickson D, Murphy MP, Golde TE: Amyloid-β immunization effectively reduces amyloid deposition in FcRγ -/- knock-out mice. J Neurosci 2003; 23: 8532-8538.
    • (2003) J Neurosci , vol.23 , pp. 8532-8538
    • Das, P.1    Howard, V.2    Loosbrock, N.3    Dickson, D.4    Murphy, M.P.5    Golde, T.E.6
  • 63
    • 78650507352 scopus 로고    scopus 로고
    • Modified immunotherapies against Alzheimer's disease: Toward safer and effective amyloid clearance
    • Wang YJ, Zhou HD, Zhou XF: Modified immunotherapies against Alzheimer's disease: toward safer and effective amyloid clearance. J Alzheimers Dis 2010; 21: 1065-1075.
    • (2010) J Alzheimers Dis , vol.21 , pp. 1065-1075
    • Wang, Y.J.1    Zhou, H.D.2    Zhou, X.F.3
  • 64
    • 84865676982 scopus 로고    scopus 로고
    • Engineered antibody approaches for Alzheimer's disease immunotherapy
    • Robert R, Wark KL: Engineered antibody approaches for Alzheimer's disease immunotherapy. Arch Biochem Biophys 2012; 526: 132-138.
    • (2012) Arch Biochem Biophys , vol.526 , pp. 132-138
    • Robert, R.1    Wark, K.L.2
  • 69
    • 78650065372 scopus 로고    scopus 로고
    • Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model
    • Boutajangout A, Quartermain D, Sigurdsson EM: Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. J Neurosci 2010; 30: 16559-16566.
    • (2010) J Neurosci , vol.30 , pp. 16559-16566
    • Boutajangout, A.1    Quartermain, D.2    Sigurdsson, E.M.3
  • 71
    • 80051569682 scopus 로고    scopus 로고
    • Amyloid-dependent and amyloid-independent stages of Alzheimer disease
    • Hyman BT: Amyloid-dependent and amyloid-independent stages of Alzheimer disease. Arch Neurol 2011; 68: 1062-1064.
    • (2011) Arch Neurol , vol.68 , pp. 1062-1064
    • Hyman, B.T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.